Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.5B | 7.9B | 8.0B | 7.9B |
| Cost of revenue | 6.0B | 5.6B | 5.5B | 5.6B |
| Gross profit | 2.6B | 2.3B | 2.5B | 2.3B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 149M | 154M | 312M | 109M |
| Non operating interest income | ||||
| Income | 51M | 49M | 53M | 55M |
| Expense | 25M | 23M | 40M | 36M |
| Other income expense | 19M | 36M | -46M | 4M |
| Pretax income | 194M | 216M | 279M | 132M |
| Tax provision | 163M | 102M | 148M | 68M |
| Net income | 31M | 114M | 131M | 64M |
| Basic EPS | 0.0 | 0.1 | 0.1 | 0.0 |
| Diluted EPS | 0.0 | 0.1 | 0.1 | 0.0 |
| Basic average shares | 1.8B | 1.8B | 1.8B | 1.8B |
| Diluted average shares | 1.9B | 1.8B | 1.8B | 1.8B |
| EBITDA | 345M | 361M | 439M | 280M |
| Net income from continuing op. | 31M | 114M | 131M | 64M |
| Minority interests | 1M | -7M | 25M | 6M |
| Preferred stock dividends | — | — | — | — |